NMDA Receptor Antagonists Increase the Release of GLP-1 From Gut Endocrine Cells
Authors:
Open Access
- 27 April 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 13, 861311
Abstract
Type 2 diabetes mellitus (T2DM) remains one of the most pressing health issues facing modern society. Several antidiabetic drugs are currently in clinical use to treat hyperglycaemia, but there is a need for new treatments that effectively restore pancreatic islet function in patients. Recent studies reported that both murine and human pancreatic islets exhibit enhanced insulin release and β-cell viability in response to N-methyl-D-aspartate (NMDA) receptor antagonists. Furthermore, oral administration of dextromethorphan, an over-the-counter NMDA receptor antagonist, to diabetic patients in a small clinical trial showed improved glucose tolerance and increased insulin release. However, the effects of NMDA receptor antagonists on the secretion of the incretin hormone GLP-1 was not tested, and nothing is known regarding how NMDA receptor antagonists may alter the secretion of gut hormones. This study demonstrates for the first time that, similar to β-cells, the NMDA receptor antagonist MK-801 increases the release of GLP-1 from a murine L-cell enteroendocrine model cell line, GLUTag cells. Furthermore, we report the 3′ mRNA expression profiling of GLUTag cells, with a specific focus on glutamate-activated receptors. We conclude that if NMDA receptor antagonists are to be pursued as an alternative, orally administered treatment for T2DM, it is essential that the effects of these drugs on the release of gut hormones, and specifically the incretin hormones, are fully investigated.Keywords
This publication has 28 references indexed in Scilit:
- A reanalysis of mouse ENCODE comparative gene expression dataF1000Research, 2015
- Medications for type 2 diabetes: how will we be treating patients in 50 years?Diabetologia, 2015
- Neuroepithelial circuit formed by innervation of sensory enteroendocrine cellsJournal of Clinical Investigation, 2015
- Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2Genome Biology, 2014
- NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and diseaseNature Reviews Neuroscience, 2013
- The sva package for removing batch effects and other unwanted variation in high-throughput experimentsBioinformatics, 2012
- BioMart – biological queries made easyBMC Genomics, 2009
- Vesicular storage and secretion of l‐glutamate from glucagon‐like peptide 1‐secreting clonal intestinal L cellsJournal of Neurochemistry, 2005
- Gene Expression Omnibus: NCBI gene expression and hybridization array data repositoryNucleic Acids Research, 2002
- Differential Expression of Glutamate Receptor Subtypes in Rat Pancreatic IsletsJournal of Biological Chemistry, 1996